WA
CRL icon

Westfuller Advisors’s Charles River Laboratories CRL Stock Holding History

Westfuller Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.85K Hold
39
– – ﹤0.01% 506
2026
Q1 		$6.73K Sell
39
-34
-47% -$6.3K ﹤0.01% 496
2025
Q4 		$14.6K Hold
73
– – 0.01% 413
2025
Q3 		$11.4K Buy
+73
New +$11.6K 0.01% 438

Other funds holding CRL

CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
JPMIA
J.P. Marvel Investment Advisors Boston, Massachusetts $871M AUM 64.45% 1-Year Est. Return

Westfuller Advisors's CRL Position: Q2 2026 in Review

Westfuller Advisors held its Charles River Laboratories (CRL) position steady in Q2 2026 at 39 shares worth $8.85K. The position accounts for ﹤0.01% of the portfolio, ranked #506.

Westfuller Advisors first reported a position in CRL in Q3 2025 and has held it in 4 quarters since. The position peaked at $14.6K in Q4 2025. 173 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Westfuller Advisors held 39 shares of Charles River Laboratories worth $8.85K as of Q2 2026.
  • Westfuller Advisors left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Westfuller Advisors's portfolio in Q2 2026, its #506 holding.
  • Westfuller Advisors first reported a position in Charles River Laboratories in Q3 2025 and has held it in 4 quarters since.
  • Westfuller Advisors's Charles River Laboratories position peaked at $14.6K in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Westfuller Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.